Schrodinger Debt to Equity Ratio 2019-2024 | SDGR

Current and historical debt to equity ratio values for Schrodinger (SDGR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Schrodinger debt/equity for the three months ending September 30, 2024 was 0.00.
Schrodinger Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.22B $0.45B 0.49
2024-06-30 $0.21B $0.47B 0.45
2024-03-31 $0.22B $0.51B 0.44
2023-12-31 $0.25B $0.55B 0.46
2023-09-30 $0.23B $0.56B 0.41
2023-06-30 $0.23B $0.61B 0.38
2023-03-31 $0.25B $0.59B 0.42
2022-12-31 $0.24B $0.45B 0.54
2022-09-30 $0.20B $0.46B 0.43
2022-06-30 $0.20B $0.49B 0.40
2022-03-31 $0.19B $0.53B 0.36
2021-12-31 $0.20B $0.56B 0.36
2021-09-30 $0.18B $0.58B 0.32
2021-06-30 $0.11B $0.61B 0.18
2021-03-31 $0.11B $0.63B 0.18
2020-12-31 $0.12B $0.62B 0.20
2020-09-30 $0.05B $0.63B 0.08
2020-06-30 $0.05B $0.30B 0.18
2020-03-31 $0.05B $0.30B 0.18
2019-12-31 $0.06B $0.10B 0.58
2019-09-30 $0.00B $0.00B 0.00
2019-06-30 $0.00B $0.00B 0.00
2019-03-31 $0.00B $0.00B 0.00
2018-12-31 $0.03B $0.09B 0.34
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.484B $0.217B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.263B 0.00
Inspire Medical Systems (INSP) United States $5.580B 174.01
Hims & Hers Health (HIMS) United States $5.276B 134.17
Enovis (ENOV) United States $2.580B 17.49
Privia Health (PRVA) United States $2.530B 210.80
IRhythm Technologies (IRTC) United States $2.313B 0.00
Azenta (AZTA) United States $2.227B 111.05
Omnicell (OMCL) United States $2.043B 66.83
Clover Health Investments (CLOV) United States $1.684B 0.00
10x Genomics (TXG) United States $1.609B 0.00
Phreesia (PHR) United States $1.098B 0.00
Butterfly Network (BFLY) United States $0.701B 0.00
Standard BioTools (LAB) United States $0.603B 0.00
Talkspace (TALK) United States $0.559B 0.00
Fulgent Genetics (FLGT) United States $0.518B 0.00
Definitive Healthcare (DH) United States $0.491B 85.00
Health Catalyst (HCAT) United States $0.466B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
TruBridge (TBRG) United States $0.239B 69.61
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
American Well (AMWL) United States $0.123B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.075B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Zepp Health (ZEPP) China $0.038B 0.00
Movano (MOVE) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.010B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00